Scholarlink

Background <p>Hyaluronic acid (HA) fillers are widely regarded as safe and effective for soft tissue augmentation, including correction of nasolabial folds, wrinkles, lips, and facial contouring. Despite favorable clinical outcomes, long-term durability remains under investigation.</p> Objective <p>To systematically review the effects of facial HA fillers on durability, patient satisfaction, and adverse events, providing a comprehensive overview for clinical and aesthetic practice.</p> Methods <p>A systematic search was conducted in Virtual Health Library (BVS), Embase, PubMed, Web of Science, and Scopus for clinical and observational studies, case reports, and series reporting quantitative data with ≥12 months follow-up. Studies included patients treated with various HA formulations and focused on filler longevity, subjective satisfaction, and adverse effects.</p> Results <p>Twenty-four studies from 13 countries including 1,410 patients (81.8% female, 21–76 years) were analyzed. Nineteen HA brands were reported, with Restylane most frequent (21.1%). 3D volumetric assessments (64%) showed HA persistence of 50–86% at 24 months and 60–86.4% at 12 months, with one study reporting 6–9 months. Ultrasound (20%) indicated 12–36 months persistence; MRI (8%) and profilometry (4%) reported presence up to 12 months. Patient-reported satisfaction, measured via subjective scales, aligned with objective findings, declining alongside quantitative HA volume over time. Adverse effects were evaluated, with the majority immediate (72.6%) and long-term events rare (4.8%).</p> Conclusion <p>HA filler longevity is influenced by manufacturing technology, tissue mobility, and anatomical factors. All technologies demonstrated good durability, though Vycross was associated with more long-term adverse events. Subjective satisfaction mirrored objective persistence, emphasizing the clinical relevance of both assessments. Individualized product selection remains essential to achieve safe, predictable, and satisfactory outcomes.</p> Level of Evidence I <p>This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors <a href="http://www.springer.com/00266">www.springer.com/00266</a>.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Clinical Durability of Hyaluronic Acid-Based Dermal Fillers for Facial Application: A Systematic Review

  • 期刊论文

  • 发表日期：

    2025年11月19日

查看全文
  • Matheus de Castro Costa,
  • Carolina Alves Andrade,
  • Ruth Venâncio Fernandes Dantas,
  • Marcelo Germani,
  • Marília Afonso Rabelo Buzalaf,
  • Diana Gabriela Soares

摘要

Background

Hyaluronic acid (HA) fillers are widely regarded as safe and effective for soft tissue augmentation, including correction of nasolabial folds, wrinkles, lips, and facial contouring. Despite favorable clinical outcomes, long-term durability remains under investigation.

Objective

To systematically review the effects of facial HA fillers on durability, patient satisfaction, and adverse events, providing a comprehensive overview for clinical and aesthetic practice.

Methods

A systematic search was conducted in Virtual Health Library (BVS), Embase, PubMed, Web of Science, and Scopus for clinical and observational studies, case reports, and series reporting quantitative data with ≥12 months follow-up. Studies included patients treated with various HA formulations and focused on filler longevity, subjective satisfaction, and adverse effects.

Results

Twenty-four studies from 13 countries including 1,410 patients (81.8% female, 21–76 years) were analyzed. Nineteen HA brands were reported, with Restylane most frequent (21.1%). 3D volumetric assessments (64%) showed HA persistence of 50–86% at 24 months and 60–86.4% at 12 months, with one study reporting 6–9 months. Ultrasound (20%) indicated 12–36 months persistence; MRI (8%) and profilometry (4%) reported presence up to 12 months. Patient-reported satisfaction, measured via subjective scales, aligned with objective findings, declining alongside quantitative HA volume over time. Adverse effects were evaluated, with the majority immediate (72.6%) and long-term events rare (4.8%).

Conclusion

HA filler longevity is influenced by manufacturing technology, tissue mobility, and anatomical factors. All technologies demonstrated good durability, though Vycross was associated with more long-term adverse events. Subjective satisfaction mirrored objective persistence, emphasizing the clinical relevance of both assessments. Individualized product selection remains essential to achieve safe, predictable, and satisfactory outcomes.

Level of Evidence I

This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266.